Tilray Extraction EU

Cantanhede, PortugalFounded 2017

Share:X / Twitter LinkedIn Suggest a correction

About Tilray Extraction EU

Tilray's European extraction facility in Portugal produces EU-GMP certified cannabis extracts and oils for distribution across European medical cannabis markets.

Key Facts

1Operates an EU-GMP certified cannabis cultivation and extraction facility in Cantanhede, Portugal
2Supplies medical cannabis extracts to pharmacies across Germany, Italy, and other European markets

Latest News

Tilray Issues 1.6M Shares to Fund Lyphe Acquisition and Debt Reduction

5d ago

TLRY dilutes equity base with new share issuance as company pursues European expansion through Lyphe Group buyout while addressing balance sheet concerns.

TLRY and ACB Rally as Retail Traders Target Cannabis Penny Stocks

5d ago

Tilray Brands and Aurora Cannabis see renewed interest from penny stock traders, driving volume spikes amid broader cannabis sector volatility.

Cannabis Rescheduling Timeline Accelerates, Threatening TLRY Dominance

5d ago

Federal cannabis rescheduling momentum builds as regulatory milestone approaches, creating headwinds for Tilray's market positioning and competitive moat.

Tilray Eyes Beer Empire Expansion Following BrewDog Strategic Move

6d ago

Cannabis giant Tilray Brands leverages alcohol diversification strategy as company positions for broader beverage market penetration beyond core cannabis operations.

Tilray's Diversification Strategy Reshapes Cannabis Investment Thesis

11d ago

TLRY's expansion beyond cannabis into alcohol and wellness creates new valuation framework as traditional sin stock categorization becomes outdated.

View all TLRY news

Frequently Asked Questions

Why did Tilray choose Portugal for European extraction?

Portugal offers favorable climate for cannabis cultivation, competitive operating costs, and EU membership enabling export of GMP-certified products across European medical markets.

What EU markets does Tilray supply?

Tilray's Portuguese facility supplies medical cannabis extracts primarily to Germany, the largest European medical cannabis market, as well as Italy, Poland, and other EU countries.